Molecular Diagnostics
Diagnostic Technique Uses Signature Chemical Differences in Leukocyte DNA
The relative abundance of signature chemical differences in the leukocyte DNA correlates with specific cancers and other diseases, making the technique potentially valuable for diagnostics and treatment monitoring. More...24 Jul 2012

In Other News
Mid-Gestation Preeclampsia Screening Test Successfully Validated
Assay Accurately Differentiates Between Four Main Lung Cancers
Commercial Testing Service Available for Acute Myeloid Leukemia
HIV Viral Load Test Targets Two HIV-1 Genome Regions
Genetic Test Improves Noonan Syndrome Diagnosis
Protein Indicator Identified For Breast Cancer Relapse
Potential Biomarker Developed for Pancreatic Cancer
Nucleic Acid Extracted from Clinical, Research, and Environmental Samples
Molecular Marker Distinguishes Between Fast and Slow Progressing Leukemia
Next Generation Sequencing Will Be Efficient and Cost-Effective
Sebia Developing Thalassemia Diagnostic with Inserm and Inserm Transfert
Sensitive Assay Differentiates Human Papillomavirus
Rapid Whole-Genome Sequencing Tracks MRSA
Blood-Based Cancer Gene Testing Technology Launched
Baby’s Genome Deciphered Prenatally from Parents’ Lab Tests
Single Tube PCR Identifies Aneuploidies in Embryos
Dried Urine Spots Detect Cytomegalovirus in Newborns
Noninvasive Genetic Test Screens for Fetal Trisomies
Genetic Screening Shows Promise During Pregnancy
Genetic Test for Major Forms of Congenital Color Blindness Launched
Predicting Cancer Relapse Improved by High-Throughput DNA Sequencing
Novel Microbe Biomarkers Reveal Evidence of Radiation Exposure
Biomarkers Discovered for Bowel Cancer Blood Test
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.







